Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
106M
-
Number of holders
-
245
-
Total 13F shares, excl. options
-
55.2M
-
Shares change
-
+748K
-
Total reported value, excl. options
-
$3.07B
-
Value change
-
+$54.9M
-
Put/Call ratio
-
1.14
-
Number of buys
-
117
-
Number of sells
-
-117
-
Price
-
$55.64
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q4 2017
319 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q4 2017.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 245 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.2M shares
of 106M outstanding shares and own 52.26% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.29M shares), FMR LLC (5.49M shares), Vanguard Group Inc (5.08M shares), STATE STREET CORP (2.37M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.87M shares), FRED ALGER MANAGEMENT INC (1.58M shares), HealthCor Management, L.P. (1.31M shares), DEUTSCHE BANK AG\ (1.28M shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (1.17M shares), and JENNISON ASSOCIATES LLC (1.15M shares).
This table shows the top 245 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.